Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients. - PubMed - NCBI

Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients. - PubMed - NCBI

Br J Dermatol. 2017 Oct;177(4):901-902. doi: 10.1111/bjd.15886.

Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients.

Nguyen MO1,2, Nguyen HT3, Asgari MM1,2.

Author information

Comment on

• Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs. [Br J Dermatol. 2017]

PMID:

 

29052902

 

PMCID:

 

PMC5679270

 [Available on 2018-10-01]

 

DOI:

 

10.1111/bjd.15886

[Indexed for MEDLINE]